Lot numbers can be found on the outside label of a product:
(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity
-
CAS No. None
- Cat. No. CS-0165031
- Purity≥98%
- MDL No.None
*For research and further manufacturing use only, not for direct human use.
Please choose your location and provide accurate information for you
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Recommended Products
General Information
- CAS No. None
- Cat. No. CS-0165031
- Purity ≥98%
- MDL No. None
- Storage Sealed in dry,2-8℃
- Shipping Room temperature in continental US; may vary elsewhere.
- Molecular Formula C₆₄H₆₆N₁₀O₈
- Molecular Weight 1103.27
- Synonym(s) None
- SMILES O[C@H]1[C@H](COCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)C[C@H]1N4C=NC5=C(OCC6=CC=CC=C6)N=C(N)N=C45.OC7C(COCC8=CC=CC=C8)C(OCC9=CC=CC=C9)CC7N%10C=NC%11=C(OCC%12=CC=CC=C%12)N=C(N)N=C%10%11
Safety Information
Download SDS|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
|
|
Quality Control
Computational Chemistry Data
- TPSA 235.08
- LogP 9.4232
- H_Acceptors 18
- H_Donors 4
- Rotatable_Bonds 22
Similar Products
Recently Viewed Products
Leave US a Message
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Key Words
- (1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity sigma(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity manufacturer(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity price(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity structure(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity SDSbuy (1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity supplier(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity uses(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity molecular weightprice of (1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity(1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity chemical name formula of (1R,2R,3R,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol compound with (1S,2S,3S,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentanol (1:1) Entecavir Impurity